Cargando…

Molecular drivers of metastatic castrate-resistant prostate cancer: New roads to resistance

Numerous growth-inducing signaling pathways have been implicated in the development of metastatic castrate-resistant prostate cancer, but their cross-talk with androgen receptor functions remains poorly understood. A recent study published in Science Signaling by Chen et al.(1) has identified a nove...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Phoebe A., Price, Douglas K., Figg, William D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2018
Materias:	Journal Club
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6300349/ https://www.ncbi.nlm.nih.gov/pubmed/29757697 http://dx.doi.org/10.1080/15384047.2018.1449618

Ejemplares similares

Examining HSD3B1 as a possible biomarker to detect prostate cancer patients who are likely to progress on ADT
por: Handy, Whitney F., et al.
Publicado: (2020)

Dexamethasone may be the most efficacious corticosteroid for use as monotherapy in castration-resistant prostate cancer
por: Holder, S L, et al.
Publicado: (2015)

Lutetium-177-PSMA-617: A Vision of the Future
por: Chandran, Elias, et al.
Publicado: (2022)

Tissue preservation with mass spectroscopic analysis: Implications for cancer diagnostics
por: Hall, O. Morgan, et al.
Publicado: (2018)

MRI-guided focused ultrasound: new hope for drug-resistant neurological conditions
por: Bari, S., et al.
Publicado: (2023)

New treatments in Alzheimer’s disease
por: Pickrell, William O., et al.
Publicado: (2018)

Deep and lasting response and acquired resistance to BRAFV600E targeting in a low-grade ovarian cancer patient
por: Anchisi, Sandro, et al.
Publicado: (2023)

Functional impact of androgen‐targeted therapy on patients with castration‐resistant prostate cancer
por: Beer, Tomasz M., et al.
Publicado: (2022)

The New Kid on the Block: Mass Photometry
por: Graciani, Guillaume, et al.
Publicado: (2023)

Exon Junction Complex Is a Molecular Compass of N(6)-Methyladenosine Modification
por: Jung, Inhong, et al.
Publicado: (2023)

New rare genetic variants in multiple sclerosis
por: Harding, Katharine E., et al.
Publicado: (2018)

New ways of looking at an old disease: the reimagination of epilepsy
por: Mitchell, Clinton J., et al.
Publicado: (2016)

New Insights Into the Evolution of Color Terms or an Effect of Saturation?
por: Witzel, Christoph
Publicado: (2016)

Creutzfeldt–Jacob disease: new directions in diagnosis and therapeutics
por: Al-Ansari, Aseel, et al.
Publicado: (2017)

Digital phenotyping and sociological perspectives in a Brave New World
por: Lovatt, Melanie, et al.
Publicado: (2017)

Maple syrup urine disease: new insights from a zebrafish model
por: Roberts, Nathan B.
Publicado: (2012)

The New Calcium Imaging Trend (Front Cell Neurosci 2015;9:436)
por: Kim, Hyun Jin
Publicado: (2016)

A new role of growth hormone and insulin growth factor receptor type 1 in neonatal inflammatory nociception
por: Manzano-García, Alfredo, et al.
Publicado: (2017)

A New Concept for Pacemaker Activity in the Human Stomach (J Physiol 2011:589[Pt 24];6105-6118)
por: Kim, Jeong Hwan
Publicado: (2012)

P2X7: a receptor with a split personality that raises new hopes for anti-cancer therapy
por: Sarti, Alba Clara, et al.
Publicado: (2021)

A new role of growth hormone and insulin-like growth factor receptor type 1 in neonatal inflammatory nociception: response to commentary
por: Jankowski, Michael P.
Publicado: (2017)

Journal Club Review of “Avacopan for the Treatment of ANCA‐Associated Vasculitis”
por: Soulsby, William Daniel
Publicado: (2022)

New Consensus on the Management of Barrett's Dysplasia and Early Stage Esophageal Adenocarcinoma: Limited Evidence, but Best Available Guidance (Gastroenterology 2012;143:336-346)
por: Jo, Yunju
Publicado: (2012)

Cannabidiol as a treatment for epilepsy
por: Pickrell, William O., et al.
Publicado: (2017)

Journal Club: Efficacy of Tocilizumab in Early Systemic Sclerosis–Related Interstitial Lung Disease
por: Tiwari, Vivekanand, et al.
Publicado: (2021)

TRPC3: A New Target for Therapeutic Strategies in Chronic Pain–DAG-mediated Activation of Non-selective Cation Currents and Chronic Pain: (Mol Pain 2014;10:43)
por: Xia, Meng, et al.
Publicado: (2015)

What is the role of the cerebellum in the pathophysiology of dystonia?
por: Fung, W. K. W., et al.
Publicado: (2019)

The Journal Club
por: Dikshit, R K
Publicado: (2010)

The Journal Club
por: Dikshit, R. K.
Publicado: (2011)

Does 22q11.2 deletion syndrome contribute to the genetic aetiology of Parkinson’s disease?
por: Fung, W., et al.
Publicado: (2018)

Kann Androgendeprivationstherapie eine protektive Rolle bei SARS-CoV-2-Infektionen spielen?
por: Schlack, K., et al.
Publicado: (2020)

Idiopathic rapid eye movement sleep behaviour disorder: a potential gateway to the development of disease-modifying treatments in neurodegenerative disorders
por: Peall, K. J., et al.
Publicado: (2016)

Dystonia: opportunities to gain insights into underlying pathophysiological mechanisms
por: Peall, K. J., et al.
Publicado: (2017)

Challenges to improved therapeutics for metastatic castrate resistant prostate cancer: from recent successes and failures
por: Huang, Xuan, et al.
Publicado: (2012)

Protein Nanomachines
por: Strong, Michael
Publicado: (2004)

Tumour Suppressor Genes—One Hit Can Be Enough
por: Hohenstein, Peter
Publicado: (2004)

Grafting the Way to the Systemic Silencing Signal in Plants
por: Kalantidis, Kriton
Publicado: (2004)

Hearing: Travelling Wave or Resonance?
por: Bell, Andrew
Publicado: (2004)

A Wingless Flight
por: Yu, Xiang
Publicado: (2003)

Channelling Evolution: Canalization and the nervous system
por: Niven, Jeremy E
Publicado: (2004)

Cannot write session to /tmp/vufind_sessions/sess_vi1mjimcn8bqj5nf8usb683bgf